Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL COMBINATIONAL USE OF SULFONAMIDE COMPOUND
Document Type and Number:
WIPO Patent Application WO/2006/090930
Kind Code:
A1
Abstract:
A pharmaceutical composition, a kit and a method for the treatment of cancer which are characterized in that a sulfonamide compound is used in combination with a substance having an EGF inhibitory activity.

More Like This:
JPS5520701NAPHTHALENE COMPOUND AND ITS MANUFACTURE
JP2014111642COMBINATION THERAPY USING HDAC INHIBITOR
JP2003514897INDUSTRIAL APPLICABILITY: Beta-amino acid-based, aspartic acid-based and diaminopropionic acid-based factor Xa inhibitors
Inventors:
OWA TAKASHI (JP)
OZAWA YOICHI (JP)
SEMBA TARO (JP)
WAKABAYASHI TOSHIAKI (JP)
Application Number:
PCT/JP2006/304218
Publication Date:
August 31, 2006
Filing Date:
February 28, 2006
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
EISAI CO LTD (JP)
OWA TAKASHI (JP)
OZAWA YOICHI (JP)
SEMBA TARO (JP)
WAKABAYASHI TOSHIAKI (JP)
International Classes:
A61K31/18; A61K31/343; A61K31/381; A61K31/404; A61K31/498; A61K31/517; A61K31/64; A61K39/395; A61K45/00; A61P35/00; A61P43/00
Domestic Patent References:
WO2003074045A12003-09-12
WO2003035629A12003-05-01
WO2006030947A12006-03-23
WO2002098848A12002-12-12
WO2003035629A12003-05-01
WO1996033980A11996-10-31
WO1995007276A11995-03-16
WO2000050395A12000-08-31
WO1996030347A11996-10-03
Foreign References:
JPS6296459A1987-05-02
JP2004530709A2004-10-07
JPH07165708A1995-06-27
JP2004536129A2004-12-02
JP2002114710A2002-04-16
JPH0340486B21991-06-19
JP3088018B22000-09-18
JPH02291295A1990-12-03
JPH07165708A1995-06-27
US5770599A1998-06-23
JP3420549B22003-06-23
JP2002114710A2002-04-16
JP2004114710A2004-04-15
Other References:
MAZITSCHEK R. ET AL.: "Inhibitors of angiogenesis and Cancer-related receptor tyrosine kinases", CURRENT OPINION IN CHEMICAL BIOLOGY, vol. 8, 2004, pages 432 - 441, XP003002235
YANO S. ET AL.: "EGFR tyrosine kinase inhibitor "gefitinib(Iressa)" for cancer therapy", NIPPON YAKURIGAKU ZASSHI, vol. 122, 2003, pages 491 - 497, XP003002236
See also references of EP 1859793A4
SCHENA M ET AL., SCIENCE, vol. 270, 1995, pages 467 - 70
LOCKHART, D.J. ET AL., NATURE BIOTECHNOLOGY, vol. 14, 1996, pages 1675 - 1680
RHEE CH ET AL., ONCOL REP, vol. 6, 1999, pages 393 - 401
ZIMMERMANN J ET AL., ONCOGENE, vol. 19, 2000, pages 2913 - 20
KUDOH K ET AL., CANCER RES, 2000, pages 4161 - 6
ROSS DT ET AL., NAT GENET, vol. 24, 2000, pages 227 - 35
SCHERF U ET AL., NAT GENET, vol. 24, 2000, pages 236 - 44
STEEL GG ET AL., INT J RADIAT ONCOL BIOL PHYS, vol. 5, 1979, pages 85 - 91
KANO Y ET AL., INT J CANCER, vol. 50, 1992, pages 604 - 610
BIOSTATISTICS, vol. 4, 2003, pages 249 - 264
PAULL, K. D. ET AL.: "Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm", J. NATL. CANCER INST., vol. 81, 1989, pages 1088 - 1092, XP009170476, DOI: doi:10.1093/jnci/81.14.1088
MONKS, A. ET AL.: "Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines", J. NATL. CANCER INST., vol. 83, 1991, pages 757 - 766, XP002951637, DOI: doi:10.1093/jnci/83.11.757
MOLECULAR CANCER THERAPEUTICS, vol. 1, 2002, pages 275 - 286
MOSSMANN T., J. IMMUNOL. METHODS, vol. 65, 1983, pages 55 - 63
Attorney, Agent or Firm:
Kobayashi, Hiroshi c/o Abe (IKUBO & KATAYAMA Fukuoka Bldg. 9th Fl., 8-7, Yaesu 2-chom, Chuo-ku Tokyo 28, JP)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: OREXIGENIC ACTION OF SULFONAMIDE COMPOUND

Next Patent: SURROGATE MARKER FOR SULFONAMIDE COMPOUND